Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Consumer willingness to pay for pharmacy services: An updated review of the literature.

Painter JT, Gressler L, Kathe N, Slabaugh SL, Blumenschein K.

Res Social Adm Pharm. 2018 Dec;14(12):1091-1105. doi: 10.1016/j.sapharm.2018.01.010. Epub 2018 Feb 2. Review.

PMID:
29398405
2.

A Comparison of Brand and Biosimilar Granulocyte-Colony Stimulating Factors for Prophylaxis of Chemotherapy-Induced Febrile Neutropenia.

Douglas AG, Schwab P, Lane D, Kennedy K, Slabaugh SL, Bowe A.

J Manag Care Spec Pharm. 2017 Dec;23(12):1221-1226. doi: 10.18553/jmcp.2017.23.12.1221.

3.

A health plan's investigation of Healthy Days and chronic conditions.

Cordier T, Slabaugh SL, Havens E, Pena J, Haugh G, Gopal V, Renda A, Shah M, Zack M.

Am J Manag Care. 2017 Oct 1;23(10):e323-e330.

4.

Comorbid Arthritis Is Associated With Lower Health-Related Quality of Life in Older Adults With Other Chronic Conditions, United States, 2013-2014.

Havens E, Slabaugh SL, Helmick CG, Cordier T, Zack M, Gopal V, Prewitt T.

Prev Chronic Dis. 2017 Jul 27;14:E60. doi: 10.5888/pcd14.160495.

5.

Leveraging Health-Related Quality of Life in Population Health Management: The Case for Healthy Days.

Slabaugh SL, Shah M, Zack M, Happe L, Cordier T, Havens E, Davidson E, Miao M, Prewitt T, Jia H.

Popul Health Manag. 2017 Feb;20(1):13-22. doi: 10.1089/pop.2015.0162. Epub 2016 Mar 31. Review.

6.

Characteristics Relating to Adherence and Persistence to Basal Insulin Regimens Among Elderly Insulin-Naïve Patients with Type 2 Diabetes: Pre-Filled Pens versus Vials/Syringes.

Slabaugh SL, Bouchard JR, Li Y, Baltz JC, Meah YA, Moretz DC.

Adv Ther. 2015 Dec;32(12):1206-21. doi: 10.1007/s12325-015-0266-5. Epub 2015 Nov 13.

7.

Erratum to: Antidiabetic Treatment Patterns in a Medicare Advantage Population in the United States.

Slabaugh SL, Xu Y, Stacy JN, Baltz JC, Meah YA, Lian J, Moretz DC, Bouchard JR.

Drugs Aging. 2015 Nov;32(11):957. doi: 10.1007/s40266-015-0317-2. No abstract available.

PMID:
26508137
8.

Antidiabetic treatment patterns in a medicare advantage population in the United States.

Slabaugh SL, Xu Y, Stacy JN, Baltz JC, Meah YA, Lian J, Moretz DC, Bouchard JR.

Drugs Aging. 2015 Feb;32(2):169-78. doi: 10.1007/s40266-014-0235-8. Erratum in: Drugs Aging. 2015 Nov;32(11):957.

PMID:
25573537
9.

Factors associated with increased healthcare costs in Medicare Advantage patients with type 2 diabetes enrolled in a large representative health insurance plan in the US.

Slabaugh SL, Curtis BH, Clore G, Fu H, Schuster DP.

J Med Econ. 2015 Feb;18(2):106-12. doi: 10.3111/13696998.2014.979292. Epub 2014 Nov 6.

PMID:
25333214
10.
11.

Prevalence and risk of polypharmacy among the elderly in an outpatient setting: a retrospective cohort study in the Emilia-Romagna region, Italy.

Slabaugh SL, Maio V, Templin M, Abouzaid S.

Drugs Aging. 2010 Dec 1;27(12):1019-28. doi: 10.2165/11584990-000000000-00000.

PMID:
21087071
12.

Localized Rac activation dynamics visualized in living cells.

Kraynov VS, Chamberlain C, Bokoch GM, Schwartz MA, Slabaugh S, Hahn KM.

Science. 2000 Oct 13;290(5490):333-7.

Supplemental Content

Loading ...
Support Center